Stock ACHFF ARCH BIOPARTNERS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Arch Biopartners Inc.

Equities

ACHFF

CA03938C1041

Delayed OTC Markets
Other stock markets
 20:09:09 18/06/2024 BST 		5-day change 1st Jan Change
1.23 USD +1.65% Intraday chart for Arch Biopartners Inc. -2.38% +10.17%
05:39pm Arch Biopartners Obtains University of Calgary Ethics Approval to Proceed with Phase II Trial MT
01:35pm Arch Biopartners Announces University of Calgary Ethics Approval to Proceed with Phase II Trial for LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury (CS-AKI) CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ARCH BIOPARTNERS INC. Stock Arch Biopartners Inc.
 77.26M - - - - -
MODERNA, INC. Stock Moderna, Inc.
 52.85B -
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 38.87B
LONZA GROUP AG Stock Lonza Group AG
 38.24B
CELLTRION, INC. Stock Celltrion, Inc.
 26.79B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
 26.16B
  1. Stock Market
  2. Equities
  3. ACHFF Stock
  4. Charts Arch Biopartners Inc.
  5. Sector Chart
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW